Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70601-5 ◽

2006 ◽

Vol 2006 ◽

pp. 457-458

Author(s):

D.S. Miller

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

The Women s Oncology Review ◽

10.3109/14733400412331312594 ◽

2004 ◽

Vol 4 (3) ◽

pp. 205-207

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.11.014 ◽

2009 ◽

Vol 112 (3) ◽

pp. 543-552 ◽

Author(s):

Howard D. Homesley ◽

Virginia Filiaci ◽

Susan K. Gibbons ◽

Harry J. Long ◽

David Cella ◽

...

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

Faculty Opinions recommendation of A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1158196.617794 ◽

2009 ◽

Author(s):

Enrico Sartori

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a gynecologic oncology group study

The Women s Oncology Review ◽

10.1080/14733400500034431 ◽

2004 ◽

Vol 4 (4) ◽

pp. 287-289

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70277-7 ◽

2007 ◽

Vol 2007 ◽

pp. 398-399

Author(s):

S.D. Yamada

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Whole Abdominal Irradiation ◽

Abdominal Irradiation

Download Full-text

Faculty Opinions recommendation of A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1158196.618316 ◽

2009 ◽

Author(s):

Paola Gehrig

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

Faculty Opinions recommendation of Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14006.471513 ◽

2006 ◽

Author(s):

Meletios Dimopoulos

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Whole Abdominal Irradiation ◽

Abdominal Irradiation

Download Full-text

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

The Women s Oncology Review ◽

10.1080/14733400412331312594 ◽

2004 ◽

Vol 4 (3) ◽

pp. 205-207

Author(s):

Not Available Not Available

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a gynecologic oncology group study

The Women s Oncology Review ◽

10.3109/14733400500034431 ◽

2004 ◽

Vol 4 (4) ◽

pp. 287-289

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

920 POSTER A randomized phase III trial of pelvic radiotherapy versus cisplatinbased combined chemotherapy in patients with intermediate risk endometrial carcinoma: a Japan gynecologic oncology group study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81215-7 ◽

2005 ◽

Vol 3 (2) ◽

pp. 265

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Intermediate Risk ◽

Combined Chemotherapy ◽

Oncology Group ◽

Pelvic Radiotherapy ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text